Unique ID issued by UMIN | UMIN000014337 |
---|---|
Receipt number | R000016204 |
Scientific Title | Study about the efficacy of metformin to immune function in healthy volunteers. |
Date of disclosure of the study information | 2014/06/23 |
Last modified on | 2019/05/03 22:04:16 |
Study about the efficacy of metformin to immune function in healthy volunteers.
Study about the efficacy of metformin to immune function in healthy volunteers.
Study about the efficacy of metformin to immune function in healthy volunteers.
Study about the efficacy of metformin to immune function in healthy volunteers.
Japan |
healthy volunteers
Adult |
Others
YES
To examine the effect of metformin on T cells in vivo by administering metformin to healthy volunteers without malignancy.
Safety,Efficacy
Exploratory
Ability to produce cytokines (IL-2, TNF alpha, IFN gamma) and differentiation (memory, helper etc.) in peripheral blood T cells.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Medicine |
Administering metformin of 500 mg after each meal everyday for two weeks.
20 | years-old | <= |
Not applicable |
Male and Female
1. Subjects who received a full explanation of the study and gave a written informed consent.
2. Subjects who weigh 50 to 80 kg and whose BMI is 18.5 or higher and less than 25.
3. Subjects who can complain abnormal and subjective symptoms if they suffer from them during the study.
1. Subjects who have symptoms which are judged to require follow-up or treatment.
2. Subjects who have previous medical history of hepatic disease, renal disease, cardiovascular disease, endocrine disease, gastrointestinal disease, respiratory disease, blood disorders and malignancy.
3. Subjects who have previous medical history of lactic acidosis.
4. Subjects who are allergic to medicines.
5. Subjects who need to take other medicines from 7 days before the study to the end of it.
6. Subjects who have drinking habit.
7. Subjects who drink caffeine-containing beverage in daily average of 1.8 L or more (coffee, tea, green tea, cola, health drink, etc.)
8. Subjects who smoke 2 packs or more in daily average.
9. Subjects who have been enrolled in the other clinical trials within last 4 months before the administration of metformin and administered any investigational new drugs.
10. Subjects who have made a blood donation prior to the administration of metformin.
11. Subjects who have been shown any problems at health examination.
12. Pregnant wouman
13. Other subjects who are judged to be ineligible in this trial by the investigator.
20
1st name | |
Middle name | |
Last name | Shinichi Toyooka |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Clinical Genomic Medicine
2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan
086-235-7436
toyooka@md.okayama-u.ac.jp
1st name | |
Middle name | |
Last name | Mototsugu Watanabe |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of General Thoracic Surgery and Breast and Endocrinological Surgery
2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan
086-235-7265
mowatanabe@s.okayama-u.ac.jp
Okayama University Hospital
Okayama University Hospital
Other
Japan
NO
岡山大学病院(岡山県)
Okayama University Hospital(Okayama)
2014 | Year | 06 | Month | 23 | Day |
Unpublished
No longer recruiting
2014 | Year | 06 | Month | 17 | Day |
2014 | Year | 06 | Month | 18 | Day |
2015 | Year | 06 | Month | 30 | Day |
2015 | Year | 12 | Month | 21 | Day |
2015 | Year | 12 | Month | 21 | Day |
2016 | Year | 03 | Month | 31 | Day |
2014 | Year | 06 | Month | 21 | Day |
2019 | Year | 05 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016204